Bitting W Coleman 4
4 · Orchid Island Capital, Inc. · Filed Apr 1, 2026
Research Summary
AI-generated summary of this filing
Orchid Island Capital (ORC) Director Coleman Receives 3,561-Unit Award
What Happened
Bitting W. Coleman, a director of Orchid Island Capital, was granted 3,561 deferred stock units (DSUs) on April 1, 2026. The grant is reported as an award/acquisition (Form 4 code A) at $0.00 per unit, so there is no immediate cash purchase or sale value recorded in the filing. The units are derivative awards that each represent a right to receive one share of the company's common stock.
Key Details
- Transaction date: 2026-04-01. Report filed with accession 0001437749-26-010896 (period of report 2026-04-01).
- Transaction type/code: Award/Grant (A); 3,561 deferred stock units acquired at $0.00 (derivative).
- Immediate value recorded: $0.00 (no cash exchanged at grant).
- Shares owned after transaction: Not specified in the provided filing excerpt.
- Footnotes in filing: see below for payout and vesting conditions.
- Timeliness: Filing covers the same date as the transaction; no late filing flag indicated.
Context Deferred stock units are a form of compensation that give the holder the right to receive shares later (one share per unit, per the filing). According to the filing footnotes, the DSUs are 100% vested but will not be payable until the earlier of a change of control or the director’s death, disability, or separation from service. Because this is an award (not an open-market purchase or sale), it reflects compensation/long-term alignment rather than an immediate bullish or bearish trading signal.
Insider Transaction Report
- Award
Deferred Stock Units
[F1][F2]2026-04-01+3,561→ 50,289 total→ Common Stock (3,561 underlying)
Footnotes (2)
- [F1]Each deferred stock unit represents a right to receive one share of the Issuer's common stock.
- [F2]The deferred stock units are 100% vested but do not become payable until the earlier to occur of a change of control or the reporting person's death, disability, or separation from service as a director of the Issuer.